Kangmei Pharmaceutical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Guowei Liu
Chief executive officer
CN¥1.5m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.2yrs |
| CEO ownership | n/a |
| Management average tenure | 4.2yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
Subdued Growth No Barrier To Kangmei Pharmaceutical Co., Ltd. (SHSE:600518) With Shares Advancing 35%
Nov 08
We Think Kangmei Pharmaceutical's (SHSE:600518) Robust Earnings Are Conservative
Nov 06Is Kangmei Pharmaceutical (SHSE:600518) A Risky Investment?
Oct 28What Kangmei Pharmaceutical Co., Ltd.'s (SHSE:600518) P/S Is Not Telling You
Aug 03We Think Kangmei Pharmaceutical (SHSE:600518) Can Stay On Top Of Its Debt
Jun 17Kangmei Pharmaceutical's (SHSE:600518) Performance Is Even Better Than Its Earnings Suggest
May 06Kangmei Pharmaceutical Co., Ltd.'s (SHSE:600518) Price Is Out Of Tune With Revenues
Apr 10CEO
Guowei Liu (51 yo)
4.2yrs
Tenure
CN¥1,500,000
Compensation
Mr. Guowei Liu serves as the General Manager and Director of Kangmei Pharmaceutical Co., Ltd. since October 10, 2020 and serves as its Managing Director.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 4.2yrs | CN¥1.50m | no data | |
| Deputy GM & CFO | 4.2yrs | CN¥1.35m | no data | |
| Deputy GM & Secretary to the Board | 3.8yrs | CN¥1.35m | no data |
4.2yrs
Average Tenure
49yo
Average Age
Experienced Management: 600518's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 4.2yrs | CN¥1.50m | no data | |
| Director | 2.9yrs | no data | no data | |
| Independent Director | 4.2yrs | CN¥120.00k | no data | |
| Employee Supervisor | 2.9yrs | no data | 0.00039% CN¥ 141.7k | |
| Independent Director | 2.9yrs | CN¥120.00k | no data | |
| Supervisor | 2.9yrs | no data | no data |
2.9yrs
Average Tenure
52yo
Average Age
Experienced Board: 600518's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 09:50 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kangmei Pharmaceutical Co., Ltd. is covered by 17 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Pei Hui Tang | Chasing Securities |
| Peng Zou | China International Capital Corporation Limited |